The undersigned submit this petition under 21 C.F.R. § 10.30 and Sections 505 and 505-1 of the Food Drug and Cosmetic Act (21 U.S.C. §§ 355, 355-1) to request that the Commissioner of the Food and Drug Administration (FDA) take several specific measures to ensure the quality and credibility of its ongoing mifepristone safety review.
